Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model01:13

Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model

Drugs administered through various routes can lead to nonlinear elimination, resulting in complex pharmacokinetic behaviors crucial to understanding efficacious drug dosing.
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
Block Diagram Reduction01:22

Block Diagram Reduction

The process of deriving the transfer function of a control system often involves reducing its block diagram to a single block. This simplification can be achieved through a series of strategic operations, including relocating branch points and comparators. These operations preserve the overall function of the system while allowing for easier manipulation and combination of blocks.
The first step in this process is the identification and relocation of a branch point. A branch point, where a...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing quantitative clinical pharmacology competencies in Francophone Africa through an on-line learning framework.

Journal of pharmacokinetics and pharmacodynamics·2026
Same author

The double-edged nature of antibody bivalency: mathematical and experimental analysis of cell surface antigen occupancy and opsonization.

mAbs·2026
Same author

A glimpse into the future of model-informed drug discovery and development.

Advanced drug delivery reviews·2026
Same author

PBPK Modelling of PROTACs: Learnings from ARV-110 as a Case Example.

The AAPS journal·2026
Same author

TMDD Modeling for Antibodies Directed Against Soluble Targets: Parameter Values for De Novo Modeling and Simulation From Experimental Data.

Clinical pharmacology and therapeutics·2026
Same author

A hybrid PKPD agent-based model of the tumour immune interaction: effects of anti-cancer combination therapy.

Journal of pharmacokinetics and pharmacodynamics·2026

Related Experiment Video

Updated: May 24, 2026

Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver
14:28

Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver

Published on: June 27, 2025

Structural identifiability analysis and reparameterisation (parameter reduction) of a cardiovascular feedback model.

S Y Amy Cheung1, Oneeb Majid, James W T Yates

  • 1AstraZeneca R&D, Alderley Park, Macclesfield, Cheshire SK10 4TF, UK.

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|February 21, 2012
PubMed
Summary
This summary is machine-generated.

Mathematical models require structural identifiability for reliable parameter estimation. This study demonstrates how to reparameterize an unidentifiable pharmacokinetic-pharmacodynamic (PKPD) model to achieve global identifiability and improve parameter estimation.

More Related Videos

Experimental Methods to Study Human Postural Control
08:12

Experimental Methods to Study Human Postural Control

Published on: September 11, 2019

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

Related Experiment Videos

Last Updated: May 24, 2026

Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver
14:28

Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver

Published on: June 27, 2025

Experimental Methods to Study Human Postural Control
08:12

Experimental Methods to Study Human Postural Control

Published on: September 11, 2019

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

Area of Science:

  • Pharmacometrics
  • Mathematical Modeling
  • Systems Biology

Background:

  • Structural identifiability is crucial for reliable parameter estimation in mathematical models.
  • Unidentifiable models can lead to poorly determined parameter estimates when using real data.
  • Pharmacokinetic-pharmacodynamic (PKPD) models are essential tools in drug development and systems biology.

Purpose of the Study:

  • To address structural unidentifiability in a PKPD model for an alpha1A/1L-adrenoceptor partial agonist.
  • To demonstrate a step-by-step procedure for identifiability analysis and reparameterization.
  • To validate the reparameterized model against the original model and assess parameter estimation improvements.

Main Methods:

  • Structural identifiability analysis was performed on a cardiovascular nonlinear PKPD model.
  • The unidentifiable model was reparameterized through parameter list reduction.
  • Simulation studies were conducted to compare parameter estimation of the original and reparameterized models.

Main Results:

  • The initial PKPD model was confirmed to be structurally unidentifiable.
  • Reparameterization resulted in a globally identifiable model.
  • The reduced parameterization demonstrated superior performance in parameter estimation compared to the original model.
  • Both models exhibited indistinguishable input-output behavior.

Conclusions:

  • Recognizing and addressing structural unidentifiability is vital in mathematical model development.
  • Identifiability analysis and reparameterization are effective strategies to obtain unique parameter estimates.
  • The reparameterized model offers improved parameter estimation while maintaining essential model behavior.